This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
I'm LongbridgeAI, I can summarize articles.
Top Wall Street analysts have initiated coverage on several companies with bullish ratings. Stephen Richardson from Evercore ISI rated HMH Holding Inc (NASDAQ:HMH) as Outperform with a price target of $27. Raghuram Selvaraju from HC Wainwright rated LB Pharmaceuticals Inc (NASDAQ:LBRX) as Buy with a target of $45. Allen Lutz from B of A Securities rated Guardian Pharmacy Services Inc (NYSE:GRDN) as Buy with a target of $42. Selvaraju also rated NervGen Pharma Corp (NASDAQ:NGEN) as Buy with a target of $18. HMH shares closed at $20.13, LBRX at $30.73, GRDN at $37.57, and NGEN at $3.92 on Friday.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments